# EDGAR Filing Document

**Accession Number:** 0001673743
**File Stem:** 0001193125-25-218082
**Filing Date:** 2025-9
**Character Count:** 8382
**Document Hash:** d38db4703da84e90c9d98c06375104bb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-218082.hdr.sgml**: 20250925

**ACCESSION NUMBER**: 0001193125-25-218082

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250924

**FILED AS OF DATE**: 20250925

**DATE AS OF CHANGE**: 20250925

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Mecklenburg Gabriel M.I.
- **CENTRAL INDEX KEY:** 0002062781

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42657
- **FILM NUMBER:** 251345026

**MAIL ADDRESS:**
- **STREET 1:** C/O HINGE HEALTH, INC.
- **STREET 2:** 455 MARKET STREET, 7TH FLOOR
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Hinge Health, Inc.
- **CENTRAL INDEX KEY:** 0001673743
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 811884841
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 455 MARKET STREET
- **STREET 2:** 7TH FLOOR
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105
- **BUSINESS PHONE:** 415-689-8429

**MAIL ADDRESS:**
- **STREET 1:** 455 MARKET STREET
- **STREET 2:** 7TH FLOOR
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Mecklenburg Gabriel M.I.<br><sub>(Last) (First) (Middle)</sub><br>C/O HINGE HEALTH, INC.<br>455 MARKET STREET, SUITE 700<br><sub>(Street)</sub><br>SAN FRANCISCO, CA 94105<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-09-24 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [X] Other (specify below)<br>_Exec. Chairman & Co-Founder_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Hinge Health, Inc. [ HNGE ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Option | $0.30 | 2025-09-24 |  | M |  |  | 42969 | <sup>(1)</sup> | 2027-11-16 | Class B Common Stock | 42969 | $0 | 0 | D |  |
| Class B Common Stock | <sup>(2)</sup> | 2025-09-24 |  | M |  | 42969<sup>(3)</sup> |  | <sup>(2)</sup> | <sup>(2)</sup> | Class A Common Stock | 42969 | $0.30 | 2670180 | D |  |
| Stock Option | $0.73 | 2025-09-24 |  | M |  |  | 107813 | <sup>(1)</sup> | 2028-09-23 | Class B Common Stock | 107813 | $0 | 0 | D |  |
| Class B Common Stock | <sup>(2)</sup> | 2025-09-24 |  | M |  | 107813<sup>(3)</sup> |  | <sup>(2)</sup> | <sup>(2)</sup> | Class A Common Stock | 107813 | $0.73 | 2777993 | D |  |
| Stock Option | $0.73 | 2025-09-24 |  | M |  |  | 60157 | <sup>(1)</sup> | 2029-01-20 | Class B  Common Stock | 60157 | $0 | 0 | D |  |
| Class B Common Stock | <sup>(2)</sup> | 2025-09-24 |  | M |  | 60157<sup>(3)</sup> |  | <sup>(2)</sup> | <sup>(2)</sup> | Class A Common Stock | 60157 | $0.73 | 2838150 | D |  |
| Stock Option | $0.84 | 2025-09-24 |  | M |  |  | 84320 | <sup>(1)</sup> | 2029-09-16 | Class B Common Stock | 84320 | $0 | 1097 | D |  |
| Class B Common Stock | <sup>(2)</sup> | 2025-09-24 |  | M |  | 84320<sup>(3)</sup> |  | <sup>(2)</sup> | <sup>(2)</sup> | Class A Common Stock | 84320 | $0.84 | 2922470 | D |  |
| Stock Option | $1.90 | 2025-09-24 |  | M |  |  | 31548 | <sup>(1)</sup> | 2030-05-05 | Class B Common Stock | 31548 | $0 | 539387 | D |  |
| Class B Common Stock | <sup>(2)</sup> | 2025-09-24 |  | M |  | 31548<sup>(3)</sup> |  | <sup>(2)</sup> | <sup>(2)</sup> | Class A Common Stock | 31548 | $1.90 | 2954018<sup>(4)</sup> | D |  |
| Class B Common Stock | <sup>(2)</sup> |  |  |  |  |  |  | <sup>(2)</sup> | <sup>(2)</sup> | Class A Common Stock | 1092119 |  | 1092119 | I | By GRAT |
| Class B Common Stock | <sup>(2)</sup> |  |  |  |  |  |  | <sup>(2)</sup> | <sup>(2)</sup> | Class A Common Stock | 383592 |  | 383592 | I | By Family Trust |

---

### Footnotes:

(1) The stock option is fully vested and currently exercisable.

(2) Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation.

(3) Represents the exercise of options to purchase Class B Common Stock by the Reporting Person. No shares were sold by the Reporting Person, and the shares received upon the exercise of such options are subject to a lock-up agreement with the underwriters in connection with the Issuer's recent initial public offering.

(4) Includes 944,250 PSUs, which vest in accordance with the terms of the award. Each PSU represents a contingent right to receive one share of Class B Common Stock.

**Signature:** /s/ David Wood, Attorney-in-Fact  
**Date:** 2025-09-25

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**